A Review of Aflibercept Treatment for Macular Disease

Aflibercept is a fully human recombinant fusion protein that includes the second domain of human VEGF receptor 1 and the third domain of human VEGF receptor 2. Despite the important role played by VEGF in maintaining the physiological condition of the retina under normal conditions, dysregulation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Anguita, Rodrigo, Tasiopoulou, Anastasia, Shahid, Syed, Roth, Janice, Sim, Sing Yue, Patel, Praveen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319283/
https://www.ncbi.nlm.nih.gov/pubmed/34120317
http://dx.doi.org/10.1007/s40123-021-00354-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319283/
https://www.ncbi.nlm.nih.gov/pubmed/34120317
http://dx.doi.org/10.1007/s40123-021-00354-1

Ejemplares similares